224 related articles for article (PubMed ID: 31064995)
21. Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.
Jeon Y; Choi YH; Jang Y; Yu J; Goo J; Lee G; Jeong YK; Lee SH; Kim IS; Kim JS; Jeong C; Lee S; Bae S
Nat Commun; 2018 Jul; 9(1):2777. PubMed ID: 30018371
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
[TBL] [Abstract][Full Text] [Related]
23. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
[TBL] [Abstract][Full Text] [Related]
24. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
[TBL] [Abstract][Full Text] [Related]
25. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA.
Paul B; Chaubet L; Verver DE; Montoya G
Nucleic Acids Res; 2022 May; 50(9):5208-5225. PubMed ID: 34951457
[TBL] [Abstract][Full Text] [Related]
26. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
Swartjes T; Staals RHJ; van der Oost J
Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
[TBL] [Abstract][Full Text] [Related]
27. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
[TBL] [Abstract][Full Text] [Related]
28. Preparation and electroporation of Cas12a/Cpf1-guide RNA complexes for introducing large gene deletions in mouse embryonic stem cells.
Kissling L; Monfort A; Swarts DC; Wutz A; Jinek M
Methods Enzymol; 2019; 616():241-263. PubMed ID: 30691645
[TBL] [Abstract][Full Text] [Related]
29. Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.
Ageely EA; Chilamkurthy R; Jana S; Abdullahu L; O'Reilly D; Jensik PJ; Damha MJ; Gagnon KT
Nat Commun; 2021 Nov; 12(1):6591. PubMed ID: 34782635
[TBL] [Abstract][Full Text] [Related]
30. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
[TBL] [Abstract][Full Text] [Related]
31. Optimization of AsCas12a for combinatorial genetic screens in human cells.
DeWeirdt PC; Sanson KR; Sangree AK; Hegde M; Hanna RE; Feeley MN; Griffith AL; Teng T; Borys SM; Strand C; Joung JK; Kleinstiver BP; Pan X; Huang A; Doench JG
Nat Biotechnol; 2021 Jan; 39(1):94-104. PubMed ID: 32661438
[TBL] [Abstract][Full Text] [Related]
32. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
[TBL] [Abstract][Full Text] [Related]
33. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
Xu X; Chemparathy A; Zeng L; Kempton HR; Shang S; Nakamura M; Qi LS
Mol Cell; 2021 Oct; 81(20):4333-4345.e4. PubMed ID: 34480847
[TBL] [Abstract][Full Text] [Related]
34. A Cascade Signal Amplification Based on Dynamic DNA Nanodevices and CRISPR/Cas12a Trans-cleavage for Highly Sensitive MicroRNA Sensing.
Li X; Zhang D; Gan X; Liu P; Zheng Q; Yang T; Tian G; Ding S; Yan Y
ACS Synth Biol; 2021 Jun; 10(6):1481-1489. PubMed ID: 34011151
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity.
Marino ND; Pinilla-Redondo R; Bondy-Denomy J
Nucleic Acids Res; 2022 Jun; 50(11):6414-6422. PubMed ID: 35670674
[TBL] [Abstract][Full Text] [Related]
37. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
Zhu LJ; Holmes BR; Aronin N; Brodsky MH
PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
[TBL] [Abstract][Full Text] [Related]
38. EasyGuide Plasmids Support in Vivo Assembly of gRNAs for CRISPR/Cas9 Applications in
Jacobus AP; Barreto JA; de Bem LS; Menegon YA; Fier Í; Bueno JGR; Dos Santos LV; Gross J
ACS Synth Biol; 2022 Nov; 11(11):3886-3891. PubMed ID: 36257021
[TBL] [Abstract][Full Text] [Related]
39. Gene Disruption Using Chemically Modified CRISPR-Cpf1 RNA.
McMahon MA; Rahdar M
Methods Mol Biol; 2021; 2162():49-60. PubMed ID: 32926377
[TBL] [Abstract][Full Text] [Related]
40. Novel Prokaryotic CRISPR-Cas12a-Based Tool for Programmable Transcriptional Activation and Repression.
Schilling C; Koffas MAG; Sieber V; Schmid J
ACS Synth Biol; 2020 Dec; 9(12):3353-3363. PubMed ID: 33238093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
